Taking part in a pharmacogenetic clinical trial: assessment of trial participants understanding of information disclosed during the informed consent process

BACKGROUND: This study is the first to examine the understandings that participants have of the consent process in a pharmacogenetic trial of anti-depressant medication. METHODS: This was a qualitative cross sectional study. There were 76 participants residing in London, Mannheim, Arhuus and Poznan....

Descripción completa

Detalles Bibliográficos
Autores principales: Rose, Diana, Russo, Jasna, Wykes, Til
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847084/
https://www.ncbi.nlm.nih.gov/pubmed/24025622
http://dx.doi.org/10.1186/1472-6939-14-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847084/
https://www.ncbi.nlm.nih.gov/pubmed/24025622
http://dx.doi.org/10.1186/1472-6939-14-34

Ejemplares similares